Physician profile
Bernardo A Rojas
NPI 1861420218
$1,018.75
in general payments reported to CMS, 2019-2025
25 companies · $19.43 in 2025
The $19.43 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $20.69 · 2022: $400 · 2023: $399 · 2024: $180 · 2025: $19.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $598.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $597.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $157.52 | 2022-2024 | |
| Amgen INC. | $93.73 | 2022-2023 | Repatha |
| Pfizer INC. | $69.77 | 2022-2023 | |
| Glaxosmithkline, LLC. | $67.91 | 2022-2023 | Shingrix, Trelegy Ellipta |
| Axsome Therapeutics, INC. | $65.91 | 2023 | Sunosi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $64.35 | 2024 | Xifaxan |
| Janssen Pharmaceuticals, INC | $52.09 | 2022 | |
| Vanda Pharmaceuticals INC. | $48.93 | 2022 | |
| Lilly USA, LLC | $42.27 | 2023-2024 | Jardiance, Mounjaro, Zepbound |
| Kowa Pharmaceuticals America, INC. | $35.65 | 2022-2023 | Livalo, Seglentis |
| Kyowa Kirin, INC. | $34.22 | 2022 | |
| Abbott Laboratories | $31.45 | 2022-2023 | Freestyle Libre 3 |
| Kiniksa Pharmaceuticals, LTD. | $30.50 | 2023 | Arcalyst |
| Otsuka America Pharmaceutical, INC. | $27.98 | 2023 | Rexulti |
| Lexicon Pharmaceuticals, INC. | $24.45 | 2024 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $20.69 | 2020 | |
| Cmp Pharma, INC. | $19.90 | 2023 | Atorvaliq |
| Ultragenyx Pharmaceutical INC. | $19.88 | 2024 | Crysvita |
| Tactile Systems Technology INC | $19.43 | 2025 | Nimbl, Flexitouch Plus |
| Novo Nordisk INC | $17.04 | 2022 | |
| Exact Sciences Corporation | $16.77 | 2024 | Cologuard Collection Kit |
| Heartflow, INC. | $16.39 | 2023 | Ffrct |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $14.14 | 2022 | |
| Baxter Healthcare | $13.96 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Merck Sharp & Dohme LLC | $13.82 | 2024 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bernardo Rojas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.